Long-term safety and efficacy are observed after implantation of Zotarolimus-Eluting stent in real-world clinical practice.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

Volumn 4, Issue 3, 2008, Pages 338-344

  Lee, Chi Hang ^a   Low, Adrian F ^a   Hong, Eric C T ^a   Tai, Bee Choo ^a   Lim, Ing Haan ^a   Teo, Swee Guan ^a   Lim, Yean Teng ^a   Tan, Huay Cheem ^a  

^a Dept Medicine Endocrinol Diabet   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; DRUG DERIVATIVE; RAPAMYCIN; ZOTAROLIMUS;

AGED; ARTICLE; CORONARY ARTERY DISEASE; CORONARY ARTERY THROMBOSIS; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HOSPITAL PATIENT; HUMAN; INCIDENCE; KAPLAN MEIER METHOD; MALE; MIDDLE AGED; MORTALITY; RESTENOSIS; RETROSPECTIVE STUDY; STATISTICS; SUDDEN DEATH; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; CORONARY THROMBOSIS; DEATH, SUDDEN, CARDIAC; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INPATIENTS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; RETROSPECTIVE STUDIES; SIROLIMUS;

EID: 59049104265     PISSN: 1774024X     EISSN: None     Source Type: Journal    
DOI: 10.4244/EIJV4I3A61     Document Type: Article

References (0)